Company news
Currenc Group Inc. (NASDAQ:CURR) news
Currenc Group Inc. news releases on 6ix. Latest, Apr 14, 2022: Sera Labs Inc. Products Now Available at Walmart, Bed Bath & Beyond, CVS and Target.com
Press releases — page 2
Sera Labs Inc. Products Now Available at Walmart, Bed Bath & Beyond, CVS and Target.com
April 13, 2022
CURE Pharmaceutical and Milagro Pharmaceuticals Collaborate for Registration and Approval to Sell Sildenafil Oral Thin Film in Mexico
March 2, 2022
Sera Labs, a Subsidiary of CURE Pharmaceutical, Consummates Exclusive International Distribution Agreement With Leading Canadian Distributor
December 8, 2021
CURE Pharmaceutical Receives Patent Approval for Its CUREfilm Blue™ Technology
November 15, 2021
CURE Pharmaceutical Reports Second Quarter 2021 Revenue Rose Nearly 700% Driven by Sales from Sera Labs Product Lines
August 16, 2021
Seratopical Revolution Skincare Line by The Sera Labs Inc., a CURE Pharmaceutical Company, will be Available for Purchase this Fall at CVS, one of the Leading National Drug Store Chains
August 3, 2021
CURE Pharmaceutical to Present at H.C. Wainwright 2021 Psychedelics in Psychiatry and Beyond Virtual Conference
June 14, 2021
CURE Pharmaceutical Signs Agreement to Develop CBD and THC Oral Thin Films and Conduct Clinical Studies Targeting Veteran Health
June 9, 2021
Nicole Kidman and Sera Labs Inc., a CURE Pharmaceutical Company, Launch Seratopical Revolution and New Ad Campaign
June 8, 2021
CURE Pharmaceutical Schedules Investor Webcast for Thursday, May 27, 2021
May 24, 2021
CURE Pharmaceutical First Quarter Revenue Quadruples to $1.5 million; Company Expands Clinical Pipeline to Include Psychedelics
May 16, 2021
CURE Pharmaceutical Receives ISO Certification for Laboratory and Manufacturing Facility
May 12, 2021
Nicole Kidman, Sera Labs Strategic Business Partner/Global Brand Ambassador and Nancy Duitch, Sera Labs Founder/CEO Headline Collision 2021 and Talk the Future of Beauty Technology
April 27, 2021
CURE Pharmaceutical Announces Successful Results From Initial Clinical Trials for Erectile Dysfunction Product CUREfilm Blue™
April 20, 2021
CURE Pharmaceutical to Present at the 2021 Sequire Cannabis Conference on Tuesday, April 20, at 2 p.m. EDT/11 a.m. PDT
April 18, 2021
Nicole Kidman, Sera Labs Strategic Business Partner/Global Brand Ambassador and Nancy Duitch, Sera Labs Founder/CEO Headline Collision 2021
April 12, 2021
CURE Pharmaceutical Reports Increase in Revenue to $7.7 Million on a Pro Forma Basis in 2020
March 31, 2021
CURE Pharmaceutical Augments Its Existing U.S. DEA License in Order to Initiate Development of Its Psychedelics-Based Pharmaceutical Clinical Pipeline
March 22, 2021
CURE Pharmaceutical Launches Psychedelic Oral Film Program Targeting the Treatment of Mental Health Disorders
March 15, 2021
CURE Pharmaceutical Announces Addition of Two New Clinical Development Programs Targeting Anti-Seizure and Antiviral Applications
March 9, 2021
CURE Pharmaceutical’s Subsidiary Sera Labs Launches National Television, Radio & Digital Advertising Campaign for Nutri-Strips Sleep A.S.A.P.
March 2, 2021
CURE Pharmaceutical Announces the Initiation of Clinical Trials for Erectile Dysfunction Product CUREfilm Blue™
February 22, 2021
CURE Pharmaceutical Announces Promotions and Additions to Board of Directors
February 10, 2021
Sera Labs Unveils ImmunD₃™ an Important New Offering to the Nutri-Strips™ Product Line; Launches New Digital E-commerce Website to Amplify Consumer Awareness
February 9, 2021
Sera Labs, Inc. Wins Prestigious Retail Excellence Award
February 1, 2021
CURE Pharmaceutical to Present at 2021 NobleCon17 on Tuesday, January 19 at 3pm EST/12pm PST
January 18, 2021
CURE Pharmaceutical to Present at H.C. Wainwright BioConnect 2021 Virtual Conference
January 6, 2021
CURE Pharmaceutical Receives FDA Approval for its IND Application for Erectile Dysfunction Product CUREfilm Blue™
January 4, 2021
CURE Pharmaceutical to Present at LD Micro on December 15, Schedules Investor Video Webcast for December 17
December 13, 2020
Nicole Kidman Partners With Sera Labs A CURE Pharmaceutical Company As A Strategic Business Partner And Global Brand Ambassador
December 9, 2020
Nicole Kidman Partners With SeraLabs, a CURE Pharmaceutical Company, as a Strategic Business Partner and Global Brand Ambassador
December 7, 2020
CURE Pharmaceutical Issues Letter to Shareholders
November 17, 2020
CURE Pharmaceutical Closes $10 Million Financing
November 1, 2020
CURE Pharmaceutical’s® Wholly Owned Subsidiary SeraLabs® Introduces Nutri-Strips™, a Revolutionary Oral Thin Film Strip Technology
October 28, 2020
CURE Pharmaceutical Completes $20 Million Acquisition of Sera Labs, a Leading Health, Wellness and Beauty Brand Marketing and Multi-Channel Distribution Platform Company
September 23, 2020
CURE Pharmaceutical to Present at Two Virtual Events in September
September 1, 2020
Sera Labs, a Leader in the CBD Industry with Proprietary Products and Multi-Channel Distribution Platform, to be acquired by CURE Pharmaceutical in a $20 Million Transaction
July 29, 2020
CURE Pharmaceutical to Acquire Sera Labs, a Leader in the CBD Industry with Proprietary Products and Multi-Channel Distribution Platform, in a $20 Million Transaction
July 27, 2020
CURE Pharmaceutical CBD Oral Thin Film Pharmacokinetic Study Shows Improved Bioavailability Compared to CBD Soft Gel
July 14, 2020
CURE Pharmaceutical Receives NSF’s cGMP Certification for Dietary Supplements
July 7, 2020
CURE Pharmaceutical Appoints Chief Business Officer
June 15, 2020
CURE Pharmaceutical Announces Exercise of Warrants for Cash Proceeds of Approximately $1.4 Million and Completes Earn Out Related to 2019 Acquisition
June 8, 2020
CURE Pharmaceutical [OTCQB:CURR] Expands to Mexico in Collaboration with Factoria Bogar Subsidiary
June 2, 2020
CURE Pharmaceutical [OTCQB:CURR] Expands Cannabis Extraction Patents, Adding Support for CBG for Therapeutic Solutions
April 20, 2020
CURE Pharmaceutical [OTCQB:CURR] Licenses Cannabis Extraction Patents to Vanguard Scientific
February 11, 2020
UPDATE – CURE Pharmaceutical [OTCQB:CURR] Expands to Europe, Signs Licensing Agreement with ReLeaf Europe to Provide Advanced Cannabinoid Delivery
February 4, 2020
CURE Pharmaceutical [OTCQB:CURR] Expands to Europe, Signs Licensing Agreement with ReLeaf Europe to Provide Advanced Cannabinoid Delivery
February 4, 2020